This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Chaoshe Guo, MD, PhD
Vice President, Global Head of Business Development at Biocytogen


Dr. Guo graduated from University of Goettingen & Max-Planck-Institute of Biophysical Chemistry, Germany and received a doctoral degree in Biochemistry in November, 2003, where he worked on the functional study of molecular chaperones via biochemistry, structural biology, and gene knockout mouse models. In 2005-2013, Dr. Guo has focused on cardiovascular and blood system development in Boston Children’s Hospital/Harvard Medical School. His research has been published in JCI, Development, and other highly reputed journals. Dr. Guo is experienced in animal model generation and phenotype analysis. In October, 2013, Dr. Guo served as the Senior R&D Director and Key Account Manager of Beijing Biocytogen Co., Ltd, to help the company establish CRISPR based gene editing platform and marketing promotion, and also got involved in humanized immune checkpoint animal model generation. Since June 2015, Dr. Guo served as the Vice President of Marketing and Global Head of Business Development.

Agenda Sessions

  • RenMabTM Mouse and In Vivo Efficacy-based Solution Empower Fully Human Antibody Drug Discovery